It appears that the use of bioresorbable vascular scaffolds (BVS) in patients undergoing percutaneous coronary intervention is linked to higher thrombotic risk and reduced efficacy over time compared with metallic everolimus-eluting stents (EES), a recent study suggests.
The risk of cardiovascular morbidity is reduced in elderly patients who highly adhere to antihypertensive drug therapy, reports a new study. Furthermore, adherence to antihypertensives also lowers the risk of heart failure and stroke, but not myocardial infarction (MI), and extending to all-cause death.
Occasional and weekly chest pain and shortness of breath during activity in patients with cardiovascular disease (CVD) appear to be associated with several modifiable patient characteristics such as weight, psychological health and number of other painful body sites, a study has shown.
While propensity score (PS) matching yielded no significant difference in the sustained virological response 24 weeks after therapy (SVR24) rates between telaprevir (TPV) with pegylated-interferon and ribavirin (PR) and boceprevir (BOC)/PR, PS matching is still a useful tool for eliminating the bias in nonrandomized studies and assessing treatment efficacy in real world settings, a new study shows.
Compared with other models of care, nurse-led care (NLC) for patients with rheumatoid arthritis (RA) is effective, acceptable and safe, according to a recent study. However, current evidence is limited to draw conclusions on its accessibility, appropriateness and efficiency.
Statins appear to have a dose-dependent association with the risk of tuberculosis (TB), with a nationwide population-based study showing that statin users have 47 percent lower incidence of TB compared with nonusers.
At a recent lunch symposium during the 14th Annual Scientific Meeting of the Malaysian Society of Hypertension, Dr Chow Yok Wai spoke on the importance of patient adherence in the management of hypertension, highlighting the role of combination therapy in improving treatment outcomes.
Individuals with high fasting plasma glucose (FPG) lost more weight than those who had low FPG in response to a high-fibre, low glycaemic load diet, suggesting that FPG could be used as a biomarker to predict dietary weight loss success and to guide selection of the most effective diet, in particular for those with prediabetes and diabetes, according to studies presented at ADA 2017.